Sherin Al-Safadi
Directeur Technique/Scientifique/R&D chez RADIOPHARM THERANOSTICS LIMITED
Profil
Sherin Al-Safadi is currently the Vice President-Medical & Corporate Affairs at Radiopharm Theranostics Ltd.
She previously worked as the Director-Global Medical Affairs Oncology Strategy at Bayer Pharmaceuticals Corp.
and as the Vice President-Medical Affairs at POINT Biopharma Global, Inc. She holds a graduate degree from McGill University, a doctorate from Concordia University, and an MBA from John Molson School of Business.
Postes actifs de Sherin Al-Safadi
| Sociétés | Poste | Début |
|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Directeur Technique/Scientifique/R&D | 24/07/2023 |
Anciens postes connus de Sherin Al-Safadi
| Sociétés | Poste | Fin |
|---|---|---|
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| POIT BIOP | Directeur Technique/Scientifique/R&D | - |
Formation de Sherin Al-Safadi
| Concordia University | Doctorate Degree |
| McGill University | Graduate Degree |
| John Molson School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| POIT BIOP | Health Technology |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Entreprise privées | 1 |
|---|---|
| Bayer Pharmaceuticals Corp. |
